ADVFN ADVFN

Hot Features

Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
Mustang Bio Inc

Mustang Bio Inc (MBIO)

0.6999
-0.0099
( -1.39% )
更新日時: 01:37:14

Mustang Bio Inc (MBIO) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

主要統計と詳細

通貨
0.6999
( -1.39% )
買値
0.69
売値
0.7098
出来高
4,483
平均取引量 (3 か月)
US$ 133,667
財務取引量
US$ 3,160
0.684 日の範囲 0.72
0.5306 52 週間の範囲 7.00
時価総額
企業価値
-10.932M
前日終値
0.7098
始値
0.72
最終取引時間
02:59:12
VWAP
0.704904
歳入
-
純利益
-2.72M
発行済株式数
7,576,785
浮動株比率 (%)
70.57%
機関投資家保有比率 (%)
19.57%
配当利回り
PER
-1.52
株価売上高倍率 (PSR)
-
1 株当たり利益 (EPS)
-0.46
ベータ
2.05

Mustang Bio Inc について

Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating cell therapies into cures for difficult-to-treat cancers and autoimmune diseases in the United States. The company develops MB-106, a CD20-targeted chimeric antigen receptor (CAR) T cell therapy which is in Phase I... Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating cell therapies into cures for difficult-to-treat cancers and autoimmune diseases in the United States. The company develops MB-106, a CD20-targeted chimeric antigen receptor (CAR) T cell therapy which is in Phase I clinical trail for non-hodgkin lymphoma, chronic lymphocytic leukemia, and autoimmune diseases; MB-109, a combination MB-101 and MB-108 as a potential treatment for IL13Ra2+ relapsed or refractory glioblastoma and high-grade astrocytoma; MB-101, an IL13Ra2 CAR T cell program completd Phase I for glioblastoma; and MB-108 which is in Phase I for the treatment of herpes simplex virus-1 oncolytic virus C134. It has a license agreement with city of hope national medical center and nationwide children’s hospital. Mustang Bio, Inc. was incorporated in 2015 and is headquartered in Waltham, Massachusetts. 詳細を表示

セクター
Healthcare
業界
Biotechnology & Life Sciences
ウェブサイト
本社
Waltham, United States
設立
2026
Mustang Bio Inc is listed in the Healthcare sector of the ナスダック市場 with ticker MBIO. The last closing price for Mustang Bio was US$0.71. Over the last year, Mustang Bio shares have traded in a share price range of US$ 0.5306 to US$ 7.00.

Mustang Bio currently has 7,576,785 shares in issue. The market capitalisation of Mustang Bio is US$5.30 million. Mustang Bio has a price to earnings ratio (PE ratio) of -1.52.

MBIO 最新ニュース

期間 †前日比前日比 %始値高値安値平均出来高VWAP
10.02273.352037802720.67720.7350.6604330230.70405359CS
40.01952.865961199290.68040.8480.625566340.71457706CS
12-0.0141-1.974789915970.7140.8480.58021345300.6865618CS
26-0.3901-35.78899082571.091.20.53061477570.73867125CS
52-2.8601-80.33988764043.5670.530614138243.08024658CS
156-5.0001-87.72105263165.770.106638688850.914475CS
260-2.4101-77.49517684893.118.170.106625984050.97493001CS

MBIO - Frequently Asked Questions (FAQ)

What is the current Mustang Bio Inc share price?
The current share price of Mustang Bio Inc is US$ 0.6999
How many Mustang Bio Inc shares are in issue?
Mustang Bio Inc has 7,576,785 shares in issue
What is the market cap of Mustang Bio Inc?
The market capitalisation of Mustang Bio Inc is USD 5.3M
What is the 1 year trading range for Mustang Bio Inc share price?
Mustang Bio Inc has traded in the range of US$ 0.5306 to US$ 7.00 during the past year
What is the PE ratio of Mustang Bio Inc?
The price to earnings ratio of Mustang Bio Inc is -1.52
What is the registered address of Mustang Bio Inc?
The registered address for Mustang Bio Inc is 95 Sawyer Road, Waltham, Massachusetts, 02453
What is the Mustang Bio Inc website address?
The website address for Mustang Bio Inc is www.mustangbio.com
Which industry sector does Mustang Bio Inc operate in?
Mustang Bio Inc operates in the Biotechnology & Life Sciences sector

MBIO 取引

さらに

取引は遅延しています

リアルタイムの取引を取得するには、アカウントをアップグレードしてください

リアルタイムにアップグレード

MBIO Discussion

投稿を表示